<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Forty-two arteriovenous grafts were placed to provide vascular access in 40 patients with poor or sclerosed superficial veins </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty-nine patients had malignant disease and required chemotherapy, while one patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> needed frequent transfusions </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty-two grafts were placed in the arm (27 straight and 5 loop), and ten in the leg (femoral-femoral loop) </plain></SENT>
<SENT sid="3" pm="."><plain>Thirty-seven shunts consisted of 6 mm <z:chebi fb="3" ids="53251">polytetrafluoroethylene</z:chebi> (<z:chebi fb="15" ids="53251">PTFE</z:chebi>), and five were 6 mm Dacron((R)) </plain></SENT>
<SENT sid="4" pm="."><plain>The straight brachial artery to axillary vein <z:chebi fb="15" ids="53251">PTFE</z:chebi> graft was preferred, while the <z:chebi fb="15" ids="53251">PTFE</z:chebi> femoral loop graft was a satisfactory alternative </plain></SENT>
<SENT sid="5" pm="."><plain>The loop arm graft was associated with a high complication rate and is no longer used </plain></SENT>
<SENT sid="6" pm="."><plain>Local anesthesia was employed in <z:hpo ids='HP_0000001'>all</z:hpo> cases except for a 3-year-old child </plain></SENT>
<SENT sid="7" pm="."><plain>There was no operative mortality and no severe morbidity, despite subsequent <z:e sem="disease" ids="C0854467" disease_type="Disease or Syndrome" abbrv="">myelosuppression</z:e> by chemotherapeutic agents injected via these grafts </plain></SENT>
<SENT sid="8" pm="."><plain>Thirty patients are alive, while ten died of their <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Twenty-six grafts are functional and have been in place an average 4.4 months (range: 1 to 14 mo.) </plain></SENT>
<SENT sid="10" pm="."><plain>Acceptance by patients and particularly by personnel in the out-patient chemotherapy unit has been enthusiastic </plain></SENT>
<SENT sid="11" pm="."><plain>Vascular access grafts can be inserted safely and provide a convenient route for drawing blood samples, and for administering chemotherapy and intermittent intravenous therapy in selected patients with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">neoplastic disease</z:e> </plain></SENT>
</text></document>